IN2014DN03373A - - Google Patents

Download PDF

Info

Publication number
IN2014DN03373A
IN2014DN03373A IN3373DEN2014A IN2014DN03373A IN 2014DN03373 A IN2014DN03373 A IN 2014DN03373A IN 3373DEN2014 A IN3373DEN2014 A IN 3373DEN2014A IN 2014DN03373 A IN2014DN03373 A IN 2014DN03373A
Authority
IN
India
Prior art keywords
compositions
water soluble
sulphate
salt
sodium
Prior art date
Application number
Other languages
English (en)
Inventor
Thomas Julius Borody
Sanjay Ramrakha
John Saxon
Antony Wettstein
Original Assignee
Borody Thomas J
Sanjay Ramrakha
John Saxon
Antony Wettstein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Borody Thomas J, Sanjay Ramrakha, John Saxon, Antony Wettstein filed Critical Borody Thomas J
Publication of IN2014DN03373A publication Critical patent/IN2014DN03373A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/5381,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN3373DEN2014 2011-10-27 2012-10-27 IN2014DN03373A (enrdf_load_html_response)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161552431P 2011-10-27 2011-10-27
US201261717599P 2012-10-23 2012-10-23
PCT/AU2012/001315 WO2013059881A1 (en) 2011-10-27 2012-10-27 Electrolyte purgatives

Publications (1)

Publication Number Publication Date
IN2014DN03373A true IN2014DN03373A (enrdf_load_html_response) 2015-06-05

Family

ID=48166953

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3373DEN2014 IN2014DN03373A (enrdf_load_html_response) 2011-10-27 2012-10-27

Country Status (14)

Country Link
US (1) US20150056140A1 (enrdf_load_html_response)
EP (1) EP2782581A4 (enrdf_load_html_response)
JP (2) JP6240610B2 (enrdf_load_html_response)
KR (1) KR20140090217A (enrdf_load_html_response)
CN (1) CN104010642B (enrdf_load_html_response)
AU (2) AU2012327212B2 (enrdf_load_html_response)
BR (1) BR112014009946A2 (enrdf_load_html_response)
CA (1) CA2853520C (enrdf_load_html_response)
IL (1) IL232218B (enrdf_load_html_response)
IN (1) IN2014DN03373A (enrdf_load_html_response)
MX (1) MX352891B (enrdf_load_html_response)
PH (1) PH12014500927B1 (enrdf_load_html_response)
RU (1) RU2640920C2 (enrdf_load_html_response)
WO (1) WO2013059881A1 (enrdf_load_html_response)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2651415T3 (pl) 2010-12-13 2021-04-19 Rite-Prep Pty Ltd. Formulacje dożołądkowe i dookrężnicze oraz sposoby ich wytwarzania i zastosowania
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
TR201904884T4 (tr) 2012-07-27 2019-05-21 Redhill Biopharma Ltd Koloni̇k boşaltmada kullanima yöneli̇k formülasyonlar ve formülasyonlarin üreti̇m yöntemleri̇
KR20170098980A (ko) 2012-09-11 2017-08-30 노어긴 비.브이. Peg 및 아스코르베이트를 포함하는 조성물
BR112015019776A2 (pt) 2013-03-15 2017-07-18 Braintree Laboratories Inc comprimidos de duplo uso oral em composições farmacêuticas de sais de sulfato e métodos de uso dos comprimidos
CN103585173B (zh) * 2013-10-28 2016-06-29 王显著 含硫酸钠和匹可硫酸的药物组合物
EP3191105A4 (en) * 2014-09-12 2018-05-02 Braintree Laboratories, Inc. Sulfate salt solution laxative compositions and methods of use thereof
FR3049464B1 (fr) * 2016-03-29 2021-08-06 Marc Girard Preparations coliques
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
KR102127003B1 (ko) * 2017-10-12 2020-06-25 주식회사 한국팜비오 황산염을 포함하는 대장 하제 조성물
CN108244627A (zh) * 2018-01-16 2018-07-06 广西天昌投资有限公司 一种具有润肠功能的香蕉口服液及其制备方法
KR102111094B1 (ko) * 2018-06-18 2020-05-14 주식회사 한국팜비오 무수황산나트륨, 황산칼륨, 무수황산마그네슘 및 시메티콘을 포함하는 장관하제 경구투여용 고형제제 조성물
RU2699222C1 (ru) * 2019-04-29 2019-09-04 Алексей Владимирович Воронов Солевой электролитный раствор для проведения энтеральных инфузий
RU2709495C1 (ru) * 2019-08-01 2019-12-18 Общество с ограниченной ответственностью "Гелеспон" Способ очищения кишечника и набор для его осуществления
WO2021133017A1 (ko) * 2019-12-23 2021-07-01 주식회사 비보존 대장 하제 조성물
KR20220033810A (ko) * 2020-09-10 2022-03-17 강윤식 장 정결용 보조 음료
WO2024256873A1 (en) 2023-06-15 2024-12-19 Sebela Ireland Limited Methods of administering safe colon cleansing compositions

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162464A (en) * 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
JP2000060487A (ja) * 1998-08-27 2000-02-29 Kao Corp 便秘改善剤
EE04580B1 (et) * 2001-06-29 2006-02-15 Tartu �likool Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
AUPS088702A0 (en) * 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
JP4458761B2 (ja) * 2003-03-27 2010-04-28 ロート製薬株式会社 瀉下用製剤
US7687075B2 (en) * 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
WO2008134071A1 (en) * 2007-04-26 2008-11-06 Theraquest Biosciences, Inc. Multimodal abuse resistant extended release formulations
WO2007057924A1 (en) * 2005-11-21 2007-05-24 Panacea Biotec Ltd Laxative composition on the basis of triphala
WO2008021394A2 (en) * 2006-08-15 2008-02-21 Theraquest Biosciences, Llc Pharmaceutical formulations of cannabinoids and method of use
JP2008115085A (ja) * 2006-11-01 2008-05-22 Tendou Seiyaku Kk 緩下剤
US20090155363A1 (en) * 2007-12-14 2009-06-18 Todd Maibach Methods for oral administration of active drugs
US20090258090A1 (en) * 2008-04-11 2009-10-15 Braintree Laboratories, Inc. Colon cleansing solution
US9040095B2 (en) * 2009-10-14 2015-05-26 Gi Innovations, Pllc Colon cleansing of residual stool and secretions during colonoscopy
JP2011135936A (ja) * 2009-12-25 2011-07-14 Toshiba Corp 画像処理装置、医用画像診断装置および画像処理プログラム
PL2651415T3 (pl) * 2010-12-13 2021-04-19 Rite-Prep Pty Ltd. Formulacje dożołądkowe i dookrężnicze oraz sposoby ich wytwarzania i zastosowania
AU2011356598B2 (en) * 2011-01-28 2017-06-01 William A. Shaver Method, composition and package for bowel cleansing

Also Published As

Publication number Publication date
JP6240610B2 (ja) 2017-11-29
CN104010642A (zh) 2014-08-27
EP2782581A1 (en) 2014-10-01
BR112014009946A2 (pt) 2017-04-25
RU2014121255A (ru) 2015-12-10
CA2853520A1 (en) 2013-05-02
EP2782581A4 (en) 2015-05-20
AU2016213892B2 (en) 2018-04-05
CN104010642B (zh) 2018-08-17
MX352891B (es) 2017-12-13
PH12014500927B1 (en) 2017-09-06
IL232218A0 (en) 2014-06-30
MX2014004962A (es) 2015-01-16
US20150056140A1 (en) 2015-02-26
JP2015510491A (ja) 2015-04-09
IL232218B (en) 2018-10-31
WO2013059881A1 (en) 2013-05-02
KR20140090217A (ko) 2014-07-16
AU2012327212A1 (en) 2013-05-23
PH12014500927A1 (en) 2014-06-16
JP2018008997A (ja) 2018-01-18
AU2016213892A1 (en) 2016-09-01
NZ624088A (en) 2016-09-30
RU2640920C2 (ru) 2018-01-12
AU2012327212B2 (en) 2016-05-12
NZ723576A (en) 2018-07-27
CA2853520C (en) 2021-11-16

Similar Documents

Publication Publication Date Title
IN2014DN03373A (enrdf_load_html_response)
CN102660749B (zh) 一种无磷脱脂剂
IN2012DN00306A (enrdf_load_html_response)
BR112012022775A2 (pt) composições para a lavagem, do cólon e métodos para a produção e utilização das mesmas
BR112012017062A2 (pt) "composições deterfgentes contendo lipase de geobacillus stearothermophilus e métodos para uso das mesmas"
MX341464B (es) Estabilización de fsh.
MX336810B (es) Benzoxazepinonas fusionadas como moduladoras de canales ionicos.
MX2014003279A (es) Composiciones detergentes que comprenden relaciones de mezclas especificas entre surfactantes basados en isoprenoides.
MX2009008279A (es) Detergente solido de disolucion rapida.
WO2011007153A8 (en) Improvements in and relating to colon cleansing compositions
GB2486127A (en) Improved deicer composition
GB201113754D0 (en) Composition
AR080992A1 (es) Una composicion de tratamiento que comprende complejos polielectrolitos
AR064483A1 (es) Composicion para lavar vajilla
RU2013131274A (ru) Жидкие очищающие композиции, содержащие длинноцепочечные жирные спирты
BR112013020101A2 (pt) composição emulsionável de limpeza de sabão concentrado
MX2011008153A (es) Composicion detergente liquida para el lavado manual de vajilla.
WO2011007174A3 (en) Composition and method
RU2011152898A (ru) Хлорированное щелочное моющее средство трубопровода с метансульфокислотой
RU2013156999A (ru) Композиции для ухода за полостью рта, содержащие фитиновую кислоту
PL2643339T3 (pl) Nowy środek hydrotropowy, jego zastosowanie do solubilizacji niejonowych środków powierzchniowo czynnych, zawierające je kompozycje
BR112012028524A2 (pt) composições farmacêuticas, respectivos usos e métodos de preparação, composição sólida solúvel em água e kits
EA201890638A1 (ru) Отклоняющие кислоты, содержащие водорастворимое замедляющее действие средство, а также способы изготовления и применения
MX2009007265A (es) Sales, composiciones liquidas acuosas que cotienen sales de acido s-(+)-abscisico y metodos para su preparacion.
EA201171466A1 (ru) Композиция неслеживающейся соли, способ ее получения и использование